Bottom line, the new management has the ship turned around and going in the right direction. Positive results on the soon to be started study or, even bigger, the dronabinol sleep apnea study, will send this sharply upward. This management is savvy about raising money and have put their own money where ours is. Regarding the delay, the NIH put in new conflict of interest-ethics requirements after the study was started and so there was a delay while researchers completed the necessary paperwork. Little money burnt from this delay.
News 
Market Data 
Discover 
